Feature

Engineering Mind Helps Investigator Develop New Cancer Therapies


 

I understand your recently awarded AACR-Waun Ki Hong Award for Outstanding Achievement in Translational and Clinical Cancer Research has special significance to you. Can you explain why that is?

Dr. Kopetz: This holds a special meaning for me, because Dr. Hong provided a lot of guidance [to me] over the years. He was the division head for cancer medicine at MD Anderson for many years and was instrumental in helping advocate [for me] and advance my career as well as the careers of so many others in and outside of the institution. I considered him a key mentor and sponsor. He helped provide me with guidance early in my oncology career, helping me identify high-value projects and critically evaluate research directions to pursue. He also helped me think about how to balance my research portfolio and provided guidance about how to work well within a team.

It’s really humbling to have a reward bearing his name as somebody who I so deeply respected, and I’m so grateful for the impact he had on my life.

Pages

Recommended Reading

Negative Colonoscopy? 15-Year Screening Interval May Be Safe
Federal Practitioner
Can a Risk Score Predict Kidney Injury After Cisplatin?
Federal Practitioner
New mRNA Vaccines in Development for Cancer and Infections
Federal Practitioner
Oral Microbiome Test Could Detect Gastric Cancer Earlier
Federal Practitioner
FDA OKs First Multitarget Stool RNA Test for CRC Screening
Federal Practitioner
Urine Tests Could Be ‘Enormous Step’ in Diagnosing Cancer
Federal Practitioner
Liposomal Irinotecan for Pancreatic Cancer: Is It Worth It?
Federal Practitioner
Obesity and Cancer: Untangling a Complex Web
Federal Practitioner
Late-Night Eaters May Have Increased Risk for Colorectal Cancer
Federal Practitioner
Chemo May Benefit Some Older Patients With Metastatic Pancreatic Cancer
Federal Practitioner